Tate & Lyle Ventures
VC Fund
London, United Kingdom
Tate & Lyle Ventures is a £25M venture capital fund focused on investing in high growth companies in the fields of renewable ingredients, food technologies, biomaterials and industrial processing technologies. Their cornerstone investor is Tate & Lyle PLC, one of the world's leading renewable ingredients companies focused oninnovation and product development in these sectors.They are proactive investors investing practically as well as financially by supporting the management teams they back with experience, strategy and networks. They prefer to work as lead investors but occasionally work as syndicate members alongside other investors such as business angels, venture capital funds and corporate investors.They can invest in businesses around the world. They invest in technology-based businesses across food science and technology. They generally make an initial investment of £1-2M followed by further amounts of follow-on investment. They consider smaller investments and seed deals when the business is on a very steep growth curve leading to greater capital requirements.
- Total investments:
- 12
- Last investment:
- Lead investor:
- 17%
Last updated:
For AI agents: llms.txt
Industries Tate & Lyle Ventures invests in
Stages Tate & Lyle Ventures invests in
Countries Tate & Lyle Ventures invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
3 more contacts available
Investment Focus
Industry
- Biotechnology 4 (33%)
- Pharmaceutical 2 (17%)
- Apps 1 (8%)
- Biofuel 1 (8%)
- Chemical 1 (8%)
Stage
- Series B 2 (17%)
- Series C 2 (17%)
- Funding Round 2 (17%)
- Seed 1 (8%)
- Series A 1 (8%)
Country
- United Kingdom 3 (25%)
- United States 2 (17%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
David Atkinson
Managing Partner
|
Managing Partner | Total investments: 5 | Find email | |
Simon Barnes
Managing Partner
|
Managing Partner | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Changing Health
|
Built on a robust base of scientific evidence, our programmes empower people with the tools and knowledge to make lasting lifestyle changes. We’ve combined health coaching rooted in behavioural psychology with engaging digital education, delivering outcomes that stand up to rigorous evaluation. This approach enables healthcare organisations aroundthe world to deliver game-changing support at scale, making the most of scarce time and resources. | $3.9M / Seed / Dec 18, 2018 | |
Prolupin
|
Prolupin GmbH is a spin-off from the Fraunhofer Institute for Process Engineering and Packaging IVV in Freising. The world-leading expertise on the fractionation of lupines and the application of this in food technology gives the business a strong position in the vegetable protein market. This position is secured by several Fraunhofer patents.The company's business activities focus on developing, producing and marketing vegetable-based, lactose-free milk substitutes from the blue sweet lupine (Lupinus angustifolius). This domestic legume is particularly rich in proteins, undemanding with regard to soil and climate and grows predominantly in Northern Germany (soybean of the north), Poland, Scandinavia, North America and Australia. With the processing technologies developed at Fraunhofer IVV, it is possible to adapt the lupine protein flavor profile in such a way as to achieve a milk-like taste. | May 08, 2018 | |
Nutriati
|
Nutriati is a food technology company focused on the research, development and commercialization of innovative plant-based food ingredients. It is dedicated to formulating nutritious food products that are widely attractive to a broad range of consumer tastes. The company's business strategy includes a commitment to positive social impactand the promotion and distribution of healthier component ingredients in the food supply, resulting in improved health and well-being globally.Nutriati was founded in 2013 and is headquartered in Richmond, Virginia, United States. | $8M / Series A / Apr 21, 2017 | |
Lumora
|
Lumora Ltd, a Cambridgeshire Business Park, UK-based molecular diagnostics company. The company intends to use the funds to accelerate its entry into the clinical molecular diagnostic market. Based on its proprietary BART Technology platform, Lumora is developing programs focusing on:- an integrated testing station for gastrointestinal (GI)infections, and- an HIV viral load monitoring system to support drug therapy in the developing world. | $917K / Mar 19, 2013 | |
Allylix
|
Allylix, Inc., an early stage biotechnology company, develops terpene products and their derivatives for the flavor and fragrance, food ingredient, pharmaceutical, agricultural, and biofuel markets. Its products comprise nootkatone, which is a grapefruit flavor that is used in fruit juices and citrus flavored sodas. The company also developssesquiterpenes that are part of aroma chemical segment of the flavor and fragrance market; and production platforms for pharmaceutical, nutraceutical, and agricultural markets. Allylix, Inc. was founded in 2002 and is based in San Diego, California with research and development laboratories in Lexington, Kentucky. | $18.2M / Mar 12, 2012 | |
|
Lumora
|
Lumora Ltd, a Cambridgeshire Business Park, UK-based molecular diagnostics company. The company intends to use the funds to accelerate its entry into the clinical molecular diagnostic market. Based on its proprietary BART Technology platform, Lumora is developing programs focusing on:- an integrated testing station for gastrointestinal (GI)infections, and- an HIV viral load monitoring system to support drug therapy in the developing world. | $2M / Series B / May 26, 2011 | |
|
Allylix
|
Allylix, Inc., an early stage biotechnology company, develops terpene products and their derivatives for the flavor and fragrance, food ingredient, pharmaceutical, agricultural, and biofuel markets. Its products comprise nootkatone, which is a grapefruit flavor that is used in fruit juices and citrus flavored sodas. The company also developssesquiterpenes that are part of aroma chemical segment of the flavor and fragrance market; and production platforms for pharmaceutical, nutraceutical, and agricultural markets. Allylix, Inc. was founded in 2002 and is based in San Diego, California with research and development laboratories in Lexington, Kentucky. | $3M / Series C / Apr 13, 2010 | |
Aquapharm Biodiscovery
|
Aquapharm is an innovative drug discovery company focussed on developing new products founded on the chemical diversity of marine micro-organisms. Their core focus is the development of novel pharmaceutical compounds leading to the development of novel antibiotics, targeting both Gram negative and Gram positive infections. In addition,Aquapharm's development pipeline is also fed by an active discovery portfolio of anti-oxidants, anti-inflammatories and novel biocatalysts. | $6.4M / Series C / Apr 05, 2010 | |
|
Allylix
|
Allylix, Inc., an early stage biotechnology company, develops terpene products and their derivatives for the flavor and fragrance, food ingredient, pharmaceutical, agricultural, and biofuel markets. Its products comprise nootkatone, which is a grapefruit flavor that is used in fruit juices and citrus flavored sodas. The company also developssesquiterpenes that are part of aroma chemical segment of the flavor and fragrance market; and production platforms for pharmaceutical, nutraceutical, and agricultural markets. Allylix, Inc. was founded in 2002 and is based in San Diego, California with research and development laboratories in Lexington, Kentucky. | $6M / Series C / Feb 10, 2010 | |
|
Allylix
|
Allylix, Inc., an early stage biotechnology company, develops terpene products and their derivatives for the flavor and fragrance, food ingredient, pharmaceutical, agricultural, and biofuel markets. Its products comprise nootkatone, which is a grapefruit flavor that is used in fruit juices and citrus flavored sodas. The company also developssesquiterpenes that are part of aroma chemical segment of the flavor and fragrance market; and production platforms for pharmaceutical, nutraceutical, and agricultural markets. Allylix, Inc. was founded in 2002 and is based in San Diego, California with research and development laboratories in Lexington, Kentucky. | $3.4M / Nov 29, 2007 | |
| See all 12 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Tate & Lyle Ventures invest in?
Tate & Lyle Ventures invests primarily in Biotechnology, Pharmaceutical and Apps startups, most often at Series B and Series C stage. Most of the 12 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Tate & Lyle Ventures?
Public channels for Tate & Lyle Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Tate & Lyle Ventures?
The team at Tate & Lyle Ventures includes David Atkinson (Managing Partner) and Simon Barnes (Managing Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
